Veracyte, Inc.
VCYT- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001384101
In the last 90 days, Veracyte, Inc. insiders filed 0 open-market purchases and 6 sales; 370 institutions reported holding it in 13F filings for Q2 2026, worth $5.23B in total; ARK Invest is the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding Veracyte, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 223 | 3 | 233 | +13 |
| Shares | 76.2M | 38.1K | 78.7M | +2.54M (+3.3%) |
| Value | $1.81B | $1.02M | $1.74B | −$66.6M (−3.7%) |
3 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (34)
Institutions that held Veracyte, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (21)
Institutions that held Veracyte, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Pictet Asset Management SA | 650,524 | $15.4M |
| Fuller & Thaler Asset Management, Inc. | 372,185 | $8.83M |
| Point72 Asset Management, L.P. | 225,815 | $5.36M |
| Lisanti Capital Growth, LLC | 112,365 | $2.67M |
| Ergoteles LLC | 99,796 | $2.37M |
| First Trust Advisors LP | 66,639 | $1.58M |
| Guggenheim Capital LLC | 41,791 | $991.7K |
| Fox Run Management, L.L.C. | 34,145 | $810.3K |
| Capital Fund Management S.A. | 31,141 | $739.0K |
| Campbell & CO Investment Adviser LLC | 28,895 | $685.7K |
| Meeder Asset Management Inc | 12,974 | $307.9K |
| Quantamental Technologies LLC | 11,877 | $281.8K |
| Axq Capital, LP | 10,383 | $246.4K |
| DuPont Capital Management Corp | 5,006 | $118.8K |
| Quantbot Technologies LP | 4,000 | $94.9K |
| Simplex Trading, LLC | 2,488 | $59.0K |
| Bessemer Group Inc | 188 | $4.00K |
| Romano Brothers and Company | 128 | $3.04K |
| Rockefeller Capital Management L.P. | 67 | $1.00K |
| Ronald Blue Trust, Inc. | 76 | $1.00K |
| Comerica Securities,inc. | 10 | $237 |
Not filed for Q1 2023 yet (3)
Institutions that held Veracyte, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Comerica Bank | 37,600 | $1.00M |
| Sargent Bickham Lagudis LLC | 400 | $9.49K |
| Heritage Wealth Management, LLC | 80 | $1.90K |